Combined antihypertensive therapy in metabolic syndrome patients
The aim of the study was to achieve target blood pressure (BP) level in metabolic syndrome (MS) patients receiving two antihypertensive medications, in order to compare systemic metabolic effects of the latter. This open study included 20 patients (12 females, 8 males), mean age 54 ± 3 years, diagno...
Saved in:
| Main Author: | M. D. Mamedov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2006-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1938 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME
by: E. I. Mananko, et al.
Published: (2016-01-01) -
ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION
by: M. V. Leonova, et al.
Published: (2015-12-01) -
Spirapril effectiveness and organo-protection in patients with metabolic syndrome and arterial hypertension
by: V. E. Oleynikov, et al.
Published: (2007-08-01) -
THE EFFICIEANCY OF KORDAFLEX-RETARD IN PATIENTS WITH ARTERIAL HYPERTENSION WITH METABOLIC DISORDERS
by: L. I. Katelnitckaya, et al.
Published: (2001-06-01) -
N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
by: A. S. Galyavich, et al.
Published: (2006-10-01)